411 related articles for article (PubMed ID: 32677481)
1. Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.
Karimian Azari E; Kerrigan A; O'Connor A
J Diet Suppl; 2020; 17(5):625-650. PubMed ID: 32677481
[TBL] [Abstract][Full Text] [Related]
2. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.
Lowe H; Toyang N; Steele B; Bryant J; Ngwa W
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502379
[TBL] [Abstract][Full Text] [Related]
3. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
Blebea NM; Pricopie AI; Vlad RA; Hancu G
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
[TBL] [Abstract][Full Text] [Related]
4. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Maccarrone M; Di Marzo V; Gertsch J; Grether U; Howlett AC; Hua T; Makriyannis A; Piomelli D; Ueda N; van der Stelt M
Pharmacol Rev; 2023 Sep; 75(5):885-958. PubMed ID: 37164640
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
[TBL] [Abstract][Full Text] [Related]
6. Terpenoids, Cannabimimetic Ligands, beyond the
Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
[TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoid System Components: Overview and Tissue Distribution.
Joshi N; Onaivi ES
Adv Exp Med Biol; 2019; 1162():1-12. PubMed ID: 31332731
[TBL] [Abstract][Full Text] [Related]
9. Beyond THC and Endocannabinoids.
Pacher P; Kogan NM; Mechoulam R
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid signaling in health and disease.
Lu Y; Anderson HD
Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
[TBL] [Abstract][Full Text] [Related]
13. Review of the Endocannabinoid System.
Lu HC; Mackie K
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):607-615. PubMed ID: 32980261
[TBL] [Abstract][Full Text] [Related]
14. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.
Ligresti A; De Petrocellis L; Di Marzo V
Physiol Rev; 2016 Oct; 96(4):1593-659. PubMed ID: 27630175
[TBL] [Abstract][Full Text] [Related]
15. Phytocannabinoid Pharmacology: Medicinal Properties of
Sampson PB
J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
[TBL] [Abstract][Full Text] [Related]
16. An overview on plants cannabinoids endorsed with cardiovascular effects.
Dimmito MP; Stefanucci A; Della Valle A; Scioli G; Cichelli A; Mollica A
Biomed Pharmacother; 2021 Oct; 142():111963. PubMed ID: 34332376
[TBL] [Abstract][Full Text] [Related]
17. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
18. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
19. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias.
Millán-Guerrero RO; Isais-Millán S
Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229
[TBL] [Abstract][Full Text] [Related]
20. The evolution of cannabinoid receptors in cancer.
Pennant NM; Hinton CV
WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
